Skip to main content

Esperion Therapeutics, Inc.

ESPRDelisted Jul 13, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001434868

Esperion Therapeutics, Inc. was delisted on Jul 13, 2026; its insiders filed their last Form 4 on Jul 13, 2026; 191 institutions reported holding it in 13F filings for Q2 2026, worth $646.8M in total; Soros Fund Management was the only superinvestor holding it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Esperion Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Esperion Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Esperion Therapeutics, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Hoffman RobertDirector0Jul 13, 20262
Carroll J MartinDirector0Jul 13, 20262
Shepard JayDirector0Jul 13, 20262
Fischer Seth H. Z.Director0Jul 13, 20262
Thompson John CraigDirector0Jul 13, 20262
Harlow John B. Jr.Chief Commercial Officer0Jul 13, 20262
Looker BenjaminChief Legal Officer0Jul 13, 20267
Halladay BenjaminChief Financial Officer0Jul 13, 20265
Koenig Sheldon L.President and CEO0Jul 13, 20265
Vitullo NicoleDirector36,918Jun 2, 20250
Rocamboli StephenDirector69,261Jun 2, 20250
Woody Tracy MDirector33,566Jun 2, 20250
Warren EricChief Commercial Officer370,218Apr 21, 20250
Foody Joanne M.Chief Medical Officer272,862Jul 19, 20240
Gotto Antonio M Jr MD D PhilDirector51,599May 24, 20240
Fuhrman AlanDirector53,404May 24, 20240
Berkowitz JeffreyDirector–May 27, 20220
Bartram RichardChief Financial Officer82,751Mar 16, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Mar 18, 2022 (view filing)Mar 171 dayKoenig Sheldon L.President and CEOSSale−571$4.58−$2.62K−0.3%194.7K after
May 18, 2022 (view filing)May 171 dayWarren EricChief Commercial OfficerSSale−196$5.98−$1.17K−0.4%53.9K after
Jun 3, 2022 (view filing)Jun 21 dayCarroll J MartinDirectorPPurchase+5.00K$5.64+$28.2KNew position5.00K after
Jun 21, 2022 (view filing)Jun 174 daysWarren EricChief Commercial OfficerSSale−256$4.90−$1.25K−0.5%53.7K after
Jun 21, 2022 (view filing)Jun 174 daysKoenig Sheldon L.President and CEOSSale−4.55K$4.99−$22.7K−2.3%190.2K after
Jul 20, 2022 (view filing)Jul 191 dayWarren EricChief Commercial OfficerSSale−431$6.58−$2.84K−0.8%53.2K after
Jul 20, 2022 (view filing)Jul 191 dayFoody Joanne M.Chief Medical OfficerSSale−3.90K$6.55−$25.6K−3.5%109.1K after
Aug 8, 2022 (view filing)Aug 53 daysKoenig Sheldon L.President and CEOPPurchase+8.61K$5.80+$49.9K+4.5%198.8K after
Aug 18, 2022 (view filing)Aug 171 dayWarren EricChief Commercial OfficerSSale−199$6.82−$1.36K−0.4%53.0K after
Aug 31, 2022 (view filing)Aug 31Same dayWarren EricChief Commercial OfficerPPurchase+1.00K$7.46+$7.46K+1.9%54.0K after
Sep 20, 2022 (view filing)Sep 191 dayKoenig Sheldon L.President and CEOSSale−3.39K$6.94−$23.6K−1.7%198.3K after
Sep 20, 2022 (view filing)Sep 191 dayWarren EricChief Commercial OfficerSSale−255$6.92−$1.76K−0.5%53.8K after
Oct 19, 2022 (view filing)Oct 181 dayWarren EricChief Commercial OfficerSSale−107$7.69−$822.83−0.2%53.7K after
Oct 19, 2022 (view filing)Oct 181 dayFoody Joanne M.Chief Medical OfficerSSale−942$7.69−$7.24K−0.9%108.1K after
Jan 19, 2023 (view filing)Jan 181 dayFoody Joanne M.Chief Medical OfficerSSale−1.19K$6.99−$8.33K−1.1%106.9K after
Jan 19, 2023 (view filing)Jan 181 dayLooker BenjaminGeneral CounselSSale−6.35K$7.00−$44.4K−9.0%64.5K after
Mar 8, 2023 (view filing)Mar 71 dayFoody Joanne M.Chief Medical OfficerSSale−3.88K$5.07−$19.7K−3.6%103.1K after
Mar 8, 2023 (view filing)Mar 71 dayKoenig Sheldon L.President and CEOSSale−5.44K$5.06−$27.5K−2.7%194.8K after
Mar 8, 2023 (view filing)Mar 71 dayWarren EricChief Commercial OfficerSSale−5.09K$5.06−$25.8K−9.5%48.6K after
Mar 20, 2023 (view filing)Mar 173 daysWarren EricChief Commercial OfficerSSale−526$1.78−$936.28−0.7%70.3K after
Mar 20, 2023 (view filing)Mar 173 daysKoenig Sheldon L.President and CEOSSale−7.00K$1.78−$12.5K−2.3%292.8K after
Mar 20, 2023 (view filing)Mar 173 daysFoody Joanne M.Chief Medical OfficerSSale−3.81K$1.78−$6.78K−2.9%128.0K after
Apr 20, 2023 (view filing)Apr 191 dayFoody Joanne M.Chief Medical OfficerSSale−938$1.27−$1.19K−0.7%127.1K after
Apr 20, 2023 (view filing)Apr 191 dayLooker BenjaminGeneral CounselSSale−1.29K$1.27−$1.64K−1.5%83.7K after
Apr 20, 2023 (view filing)Apr 191 dayWarren EricChief Commercial OfficerSSale−115$1.28−$147.2−0.2%70.2K after
May 10, 2023 (view filing)May 91 dayKoenig Sheldon L.President and CEOPPurchase+20.0K$1.26+$25.2K+6.8%312.8K after
May 11, 2023 (view filing)May 101 dayRocamboli StephenDirectorPPurchase+8.11K$1.50+$12.2KNew position8.11K after
May 11, 2023 (view filing)May 10-111 dayCarroll J MartinDirectorPPurchase+31.5K$1.55+$48.8K+630.0%36.5K after2 lots
May 18, 2023 (view filing)May 171 dayWarren EricChief Commercial OfficerSSale−219$1.62−$354.78−0.3%70.0K after
Jun 22, 2023 (view filing)Jun 211 dayWarren EricChief Commercial OfficerSSale−603$1.48−$892.44−0.9%69.4K after
Jul 20, 2023 (view filing)Jul 191 dayWarren EricChief Commercial OfficerSSale−106$1.59−$168.54−0.2%69.3K after
Aug 21, 2023 (view filing)Aug 183 daysWarren EricChief Commercial OfficerSSale−243$1.41−$342.63−0.4%69.1K after
Sep 21, 2023 (view filing)Sep 201 dayWarren EricChief Commercial OfficerSSale−742$1.25−$927.5−1.1%68.3K after
May 20, 2024 (view filing)May 173 daysWarren EricChief Commercial OfficerSSale−192$2.48−$476.16−0.1%168.1K after
Jun 20, 2024 (view filing)Jun 182 daysWarren EricChief Commercial OfficerSSale−2.54K$2.86−$7.26K−1.5%165.6K after
Jun 20, 2024 (view filing)Jun 182 daysFoody Joanne M.Chief Medical OfficerSSale−3.29K$2.87−$9.43K−1.2%273.8K after
Jul 19, 2024 (view filing)Jul 172 daysFoody Joanne M.Chief Medical OfficerSSale−917$2.60−$2.38K−0.3%272.9K after
Jul 19, 2024 (view filing)Jul 172 daysWarren EricChief Commercial OfficerSSale−108$2.59−$279.72−0.1%165.5K after
Aug 20, 2024 (view filing)Aug 191 dayWarren EricChief Commercial OfficerSSale−211$1.95−$411.45−0.1%165.3K after
Sep 18, 2024 (view filing)Sep 171 dayWarren EricChief Commercial OfficerSSale−2.61K$1.78−$4.64K−1.6%162.7K after
Sep 18, 2024 (view filing)Sep 171 dayKoenig Sheldon L.President and CEOSSale−14.6K$1.80−$26.2K−1.9%752.3K after
Oct 18, 2024 (view filing)Oct 171 dayWarren EricChief Commercial OfficerSSale−107$2.12−$226.84−0.1%162.6K after
Nov 20, 2024 (view filing)Nov 191 dayWarren EricChief Commercial OfficerSSale−197$2.17−$427.49−0.1%162.4K after
Dec 18, 2024 (view filing)Dec 171 dayKoenig Sheldon L.President and CEOSSale−12.4K$2.47−$30.7K−1.7%739.8K after
Dec 18, 2024 (view filing)Dec 171 dayWarren EricChief Commercial OfficerSSale−2.23K$2.43−$5.43K−1.4%160.1K after
Dec 18, 2024 (view filing)Dec 171 dayHalladay BenjaminChief Financial OfficerSSale−3.25K$2.42−$7.85K−1.3%240.7K after
Jan 21, 2025 (view filing)Jan 174 daysWarren EricChief Commercial OfficerSSale−123$2.26−$277.98−0.1%160.0K after
Jan 21, 2025 (view filing)Jan 174 daysHalladay BenjaminChief Financial OfficerSSale−9$2.27−$20.430.0%240.7K after
Feb 20, 2025 (view filing)Feb 191 dayHalladay BenjaminChief Financial OfficerSSale−11$1.86−$20.460.0%240.7K after
Feb 20, 2025 (view filing)Feb 191 dayWarren EricChief Commercial OfficerSSale−239$1.87−$446.93−0.1%159.8K after